Expression of oncogenes in human breast cancer specimens.
More than 60 breast cancer specimens were screened for their expression status of 25 different proto-oncogenes. The screening method is based on in vitro synthesis of a radioactive cDNA copied from the total cellular RNA of tumor tissue. This cDNA is hybridized to cloned oncogene probes which are immobilized to a GeneScreen membrane. Frequently multiple oncogenes were found expressed although expression levels were rather moderate. 25-30% of the analyzed tumors showed significant expression of either erbB, src, raf1, lck or H-ras. Although neu expression--an oncogene believed to be particular relevant as prognostic parameter for mamma carcinoma--was screened for most of the tumors with a heterologous gene probe, expression signals could be detected in about 20% cases. The only notable correlation with classical clinical parameters such as tumor size and proliferation stage, hormone receptor status and different DNA indices was the observation that tumors lacking the progesterone receptor frequently express multiple oncogenes. Advantages and limitations of the cDNA/dot-blot screening for oncogene expression are discussed.
Köster
A
A
Institut für Biochemie, Medizinischen Fakultät, Universität Erlangen-Nürnberg, F.R.G.
Landgraf
S
S
Leipold
A
A
Sachse
R
R
Gebhart
E
E
Tulusan
A H
AH
Rónay
G
G
Schmidt
C
C
Dingermann
T
T
D000818:Animals; D001943:Breast Neoplasms / Q000235:genetics* / Q000473:pathology; D003001:Cloning, Molecular; D005260:Female; D015870:Gene Expression; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D015151:Immunoblotting; D009857:Oncogenes; D011518:Proto-Oncogene Proteins / Q000032:analysis; D011519:Proto-Oncogenes; D012334:RNA, Neoplasm / Q000235:genetics / Q000302:isolation & purification
D011518:Proto-Oncogene Proteins; D012334:RNA, Neoplasm